[Cost-effectiveness analysis of ocriplasmin in the treatment of vitreomacular traction in Italy]. (2015). Farmeconomia. Health Economics and Therapeutic Pathways, 16(4), 93-102. https://doi.org/10.7175/fe.v16i4.1221